Kalisiyumu ya Atorvastatin

Ibisobanuro bigufi:

Izina rya API Kwerekana Ibisobanuro DMF yo muri Amerika EU DMF CEP
Kalisiyumu ya Atorvastatin Hypercholesterolemia Mu nzu / CEP 29057 CEP 2015-034


Ibisobanuro birambuye

Ibiranga ibicuruzwa

KUBONA UMUSARURO

Amavu n'amavuko

Kalisiyumu ya Atorvastatine ni inhibitori ya HMG-CoA reductase ifite IC50 agaciro ka 150 nM [1].
HMG-CoA reductase ni enzyme yingenzi yinzira ya mevalonate itanga cholesterol.HMG-CoA ni enzyme igabanya umuvuduko kandi ni ngombwa mu kugabanya urugero rwa cholesterol mu maraso.HMG-CoA reductase iherereye muri endoplasmic reticulum kandi irimo umunani wa transembrane.Inhibitori ya HMG-CoA reductase irashobora gutuma LDL (lipoprotein nkeya) yakira umwijima.Bitera kongera catabolisme ya plasma LDL no kugabanya ubukana bwa plasma cholesterol ikaba ari ikintu cyingenzi kigena aterosklerose.HMG-CoA reductase igira uruhare runini muri synthesis ya cholesterol.HMG-CoA niyo ntego ya imiti igabanya cholesterol.HMG-CoA reductase nayo ni enzyme yingenzi mugutezimbere.Igikorwa cya reductase ya HMG-CoA ifitanye isano nudukoko twimuka twimuka.Kubuza ibikorwa byayo birashobora gutuma umuntu ava amaraso ava mu nda [1].
Atorvastatin ni HMG-CoA reductase inhibitor ifite IC50 agaciro ka 154 nM.Ni ingirakamaro mu kuvura dyslipidemiya na hypercholesterolemia [1].Kuvura Atorvastatine kuri mg 40 bigabanya cholesterol ya 40% nyuma yiminsi 40. [1]Irakoreshwa kandi mu kuvura abarwayi ba coronary cyangwa stroke bafite cholesterol isanzwe.Atorvastatin igabanya kandi ubucucike buke bwa lipoprotein apheresis kubarwayi itera LDL-reseptors imvugo.
Ihindurwamo metabolite nyinshi zingirakamaro kubikorwa byubuvuzi na CYP3A4 (cytochrome P450 3A4). [3]
Reba:
[1].van Dam M, Zwart M, de Beer F, Smelt AH, Prins MH, Urugendo MD, Havekes LM, Lansberg PJ, Kastelein JJ: Ingaruka ndende n’umutekano wa atorvastatine mu kuvura ubwoko bukomeye bwa III hamwe na dyslipidaemia.Umutima 2002, 88 (3): 234-238.
[2].Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT nibindi: Kwirinda ibintu bya coronary na stroke hamwe na atorvastatin mubarwayi bafite hypertension bafite impuzandengo cyangwa munsi-munsi. -kugabanya ubukana bwa cholesterol, muri Anglo-Scandinaviya Yumutima Yumutima - Lipid Lowering Arm (ASCOT-LLA): ikigeragezo cyateganijwe.Lancet 2003, 361 (9364): 1149-1158.
[3].Lennernas H: Pharmacokinetics ya Clinical ya atorvastatin.Clin Pharmacokinet 2003, 42 (13): 1141-1160.

Imiterere yimiti

Atorvastatin-Calcium

CERTIFICATE

2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

Gucunga neza

Quality management1

Icyifuzo18Imishinga yo gusuzuma ireme ryemejwe4, na6imishinga iremezwa.

Quality management2

Sisitemu mpuzamahanga yo gucunga neza ubuziranenge yashyizeho urufatiro rukomeye rwo kugurisha.

Quality management3

Igenzura ryiza rinyura mubuzima bwose bwibicuruzwa kugirango hamenyekane ingaruka nziza nubuvuzi.

Quality management4

Itsinda ryumwuga ushinzwe kugenzura ibikorwa byujuje ubuziranenge mugihe cyo gusaba no kwiyandikisha.

Gucunga UMUSARURO

cpf5
cpf6

Koreya Countec Amacupa yo gupakira

cpf7
cpf8

Tayiwani CVC Icupa ryuzuye

cpf9
cpf10

Ubutaliyani CAM Ubuyobozi bwo gupakira

cpf11

Imashini yo Kudage Fette

cpf12

Ubuyapani Viswill Tablet Detector

cpf14-1

Icyumba cyo kugenzura DCS

UMUFATANYABIKORWA

Ubufatanye mpuzamahanga
International cooperation
Ubufatanye mu ngo
Domestic cooperation

  • Mbere:
  • Ibikurikira:

  • Andika ubutumwa bwawe hano hanyuma utwohereze

    Ibyiciro byibicuruzwa